These include the most strongly associated IPF risk variant in genome-wide association studies (GWAS), located at the promoter of MUC5B, which displays an opposite direction of effect in IPF and COVID-19 (i.e. the IPF risk allele was protective for COVID-19). The gene discussed is MUC5B; the disease is idiopathic pulmonary fibrosis.